296 related articles for article (PubMed ID: 17372238)
1. Differences in risk factors for breast cancer molecular subtypes in a population-based study.
Yang XR; Sherman ME; Rimm DL; Lissowska J; Brinton LA; Peplonska B; Hewitt SM; Anderson WF; Szeszenia-Dabrowska N; Bardin-Mikolajczak A; Zatonski W; Cartun R; Mandich D; Rymkiewicz G; Ligaj M; Lukaszek S; Kordek R; García-Closas M
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):439-43. PubMed ID: 17372238
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry-based subtyping of breast carcinoma in Egyptian women: a clinicopathologic study on 125 patients.
Elesawy BH; Abd El hafez A; Shawky Ael-A; Arafa M
Ann Diagn Pathol; 2014 Feb; 18(1):21-6. PubMed ID: 24321463
[TBL] [Abstract][Full Text] [Related]
3. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.
Del Casar JM; Martín A; García C; Corte MD; Alvarez A; Junquera S; González LO; Bongera M; García-Muñiz JL; Allende MT; Vizoso F
Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):147-52. PubMed ID: 18768247
[TBL] [Abstract][Full Text] [Related]
4. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies.
Sisti JS; Collins LC; Beck AH; Tamimi RM; Rosner BA; Eliassen AH
Int J Cancer; 2016 May; 138(10):2346-56. PubMed ID: 26684063
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
Wang Y; Yin Q; Yu Q; Zhang J; Liu Z; Wang S; Lv S; Niu Y
Breast Cancer Res Treat; 2011 Nov; 130(2):489-98. PubMed ID: 21837481
[TBL] [Abstract][Full Text] [Related]
6. Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women.
Horn J; Opdahl S; Engstrøm MJ; Romundstad PR; Tretli S; Haugen OA; Bofin AM; Vatten LJ; Åsvold BO
Cancer Causes Control; 2014 Jul; 25(7):881-9. PubMed ID: 24789514
[TBL] [Abstract][Full Text] [Related]
7. Identification of a basal-like subtype of breast ductal carcinoma in situ.
Livasy CA; Perou CM; Karaca G; Cowan DW; Maia D; Jackson S; Tse CK; Nyante S; Millikan RC
Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
[TBL] [Abstract][Full Text] [Related]
8. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and five years survival analysis in molecular subtypes of breast cancer.
Zaha DC; Lazăr E; Lăzureanu C
Rom J Morphol Embryol; 2010; 51(1):85-9. PubMed ID: 20191125
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for HR- and HER2-defined breast cancer in Slovenian postmenopausal women.
Cerne JZ; Ferk P; Frkovic-Grazio S; Leskosek B; Gersak K
Climacteric; 2012 Feb; 15(1):68-74. PubMed ID: 22132797
[TBL] [Abstract][Full Text] [Related]
12. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
Sánchez-Muñoz A; Román-Jobacho A; Pérez-Villa L; Sánchez-Rovira P; Miramón J; Pérez D; Sáez MI; de Luque V; Medina L; Ramírez-Tortosa CL; Vicioso L; Medina JA; Ribelles N; Alba E
Oncology; 2012; 83(4):228-33. PubMed ID: 22907070
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
14. Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study.
Puig-Vives M; Sánchez MJ; Sánchez-Cantalejo J; Torrella-Ramos A; Martos C; Ardanaz E; Chirlaque MD; Perucha J; Díaz JM; Mateos A; Machón M; Marcos-Gragera R
Gynecol Oncol; 2013 Sep; 130(3):609-14. PubMed ID: 23747837
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
16. Presenting features of breast cancer differ by molecular subtype.
Wiechmann L; Sampson M; Stempel M; Jacks LM; Patil SM; King T; Morrow M
Ann Surg Oncol; 2009 Oct; 16(10):2705-10. PubMed ID: 19593632
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a peruvian hospital database.
Vallejos CS; Gómez HL; Cruz WR; Pinto JA; Dyer RR; Velarde R; Suazo JF; Neciosup SP; León M; de la Cruz MA; Vigil CE
Clin Breast Cancer; 2010 Aug; 10(4):294-300. PubMed ID: 20705562
[TBL] [Abstract][Full Text] [Related]
18. Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
Yang XR; Pfeiffer RM; Garcia-Closas M; Rimm DL; Lissowska J; Brinton LA; Peplonska B; Hewitt SM; Cartun RW; Mandich D; Sasano H; Evans DB; Sutter TR; Sherman ME
Cancer Res; 2007 Nov; 67(21):10608-17. PubMed ID: 17968031
[TBL] [Abstract][Full Text] [Related]
19. Comparison of breast cancer risk factors among molecular subtypes: A case-only study.
Zhang L; Huang Y; Feng Z; Wang X; Li H; Song F; Liu L; Li J; Zheng H; Wang P; Song F; Chen K
Cancer Med; 2019 Apr; 8(4):1882-1892. PubMed ID: 30761775
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor receptor (NGFR): a potential marker for specific molecular subtypes of breast cancer.
Tsang JY; Wong KH; Lai MW; Lacambra MD; Ko CW; Chan SK; Lam CC; Yu AM; Tan PH; Tse GM
J Clin Pathol; 2013 Apr; 66(4):291-6. PubMed ID: 23268325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
